A heptapeptide that bind specifically to hypoxic hepatoma cells is reported.
We use a phage display peptide library for in vivo and in vitro screening to obtain this pepetide.
The binding assay indicated that the heptapeptide could specifically bind to hypoxic hepatoma cells and hepatocarcinoma tissues.
The peptide has the potential to be a useful targeting ligand for residual hepatoma cells after TACE.